Role of Radiology in Leiomyosarcoma Diagnosis and Treatment

Diagnostic Imaging

MRI is the main imaging modality for soft tissue tumors, providing superior tissue characterization and local staging information, according to the European Society for Medical Oncology 2
Standard radiographs help rule out bone tumors, detect bone erosion with fracture risk, and show calcifications, as recommended by the European Society for Medical Oncology 2
CT has equivalent performance to MRI in retroperitoneal tumors and is superior for evaluating calcified lesions, as stated by the European Society for Medical Oncology 2

Imaging-guided core needle biopsy is the standard diagnostic procedure using ≥16G needles, as recommended by the American College of Radiology 1
Radiological guidance helps avoid necrotic areas and ensures adequate tissue sampling, according to the American College of Radiology 1
For retroperitoneal leiomyosarcomas, core needle biopsies should not be performed through the peritoneum, as advised by the European Society for Medical Oncology 3, 4
The biopsy pathway must be carefully planned to avoid contamination and complications, as recommended by the European Society for Medical Oncology 3, 5

Complete staging with chest CT is essential to evaluate for pulmonary metastases, as recommended by the American College of Radiology 1
Abdominal and pelvic CT scans are required to rule out metastatic disease, according to the American College of Radiology 1
For retroperitoneal leiomyosarcomas, radiological imaging may be sufficient for diagnosis of lipomatous tumors if no preoperative treatment is planned, as stated by the European Society for Medical Oncology 3, 6
MRI helps determine tumor size, depth, and relationship to critical structures, which are crucial factors for surgical planning, as recommended by the European Society for Medical Oncology 2, 1

Imaging is vital for planning the extent of surgical resection, especially for retroperitoneal leiomyosarcomas requiring en bloc visceral resections, as advised by the European Society for Medical Oncology 3, 7
Radiological assessment helps determine whether preoperative treatments (radiation therapy, chemotherapy) are needed, according to the European Society for Medical Oncology 7, 8
For uterine leiomyosarcoma, imaging assists in determining the need for additional procedures beyond hysterectomy, as recommended by the European Society for Medical Oncology 3, 4

For high-grade leiomyosarcoma patients, follow-up should occur every 3-4 months in the first 2-3 years, then twice yearly up to the fifth year, and annually thereafter, as recommended by the European Society for Medical Oncology 3, 6
For low-grade tumors, follow-up for local relapse every 4-6 months with chest imaging at longer intervals in the first 3-5 years, then annually, according to the European Society for Medical Oncology 3, 5
MRI is preferred for local recurrence detection, while CT is used for lung metastases surveillance, as stated by the European Society for Medical Oncology 5

Imaging alone cannot definitively determine malignancy grade, which requires histopathological assessment, as recommended by the American College of Radiology 1
The natural history of leiomyosarcoma varies by location and grade, requiring tailored imaging follow-up protocols, according to the European Society for Medical Oncology 3